Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Lymphoma 128Lymphoma, Non-Hodgkin 98Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Hodgkin Disease 78Leukemia, Myeloid, Acute 74Myelodysplastic Syndromes 69Lymphoma, Large B-Cell, Diffuse 66Leukemia, Lymphocytic, Chronic, B-Cell 65Leukemia 63Lymphoma, Mantle-Cell 59Lymphoma, Follicular 57Burkitt Lymphoma 44Multiple Myeloma 40Lymphoma, Large-Cell, Immunoblastic 40Lymphoma, B-Cell, Marginal Zone 37Myeloproliferative Disorders 29Recurrence 28Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Neoplasms, Plasma Cell 24Leukemia, Myeloid, Accelerated Phase 24Leukemia, Myeloid, Chronic-Phase 23Congenital Abnormalities 22Leukemia, Myelomonocytic, Chronic 21Dendritic Cell Sarcoma, Interdigitating 21Waldenstrom Macroglobulinemia 20Graft vs Host Disease 20Primary Myelofibrosis 18Blast Crisis 17Lymphoma, T-Cell, Cutaneous 16Leukemia, Myelomonocytic, Juvenile 16

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 1 × Melphalan × Lymphoid × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡